ESMO 2023 Insights: "Phase 3 TROPION-Breast01 Trial - Datopotamab Deruxtecan Compared to Chemo in Patients With Advanced HR+/HER2- BC"

By ecancer FEATURING Aditya Bardia
By ecancer FEATURING Aditya Bardia
581 views
October 27, 2023
0 Comments
Login to view comments. Click here to Login